Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Regulatory News (COST)

Share Price Information for Costain (COST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 80.00
Bid: 80.00
Ask: 80.60
Change: -3.00 (-3.61%)
Spread: 0.60 (0.75%)
Open: 82.00
High: 82.60
Low: 79.00
Prev. Close: 83.00
COST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

No intention to make an offer for Mouchel Group

4 Apr 2011 15:21

RNS Number : 2632E
Costain Group PLC
04 April 2011
 



 

 

 

Costain Group PLC

("Costain" or the "Group")

 

No intention to make an offer for Mouchel Group plc ("Mouchel")

 

On 17 February 2011, following the completion of comprehensive initial due diligence, including extensive meetings with management, the Board of Costain submitted a revised, fully deliverable, proposal to the Board of Mouchel comprising 22.25p in cash and 0.5531 new Costain shares for each Mouchel share which, based on Costain's share price of 256.75p as at the close of business on 1 April 2011 (being the last business day prior to this announcement), valued each Mouchel share at 164.26p. The Board of Costain believes that this revised proposal did not carry any significant execution risk.

 

Following the announcement by Mouchel on 29 March 2011, the Board of Costain offered to undertake a one week period of further due diligence to reconfirm the terms of its revised proposal ahead of the remaining standard transaction implementation steps. This offer has been rejected and, having considered its options, the Board of Costain has therefore decided to withdraw its revised proposal and confirms that Costain has no intention of making an offer for Mouchel.

 

Through the Group's "Choosing Costain" strategy, Costain is making good progress in achieving its vision to be one of the UK's top solutions providers, with the scale and capability to meet successfully the increasingly complex and challenging needs of major customers. Costain's growth aspirations and ambition for the business will be achieved by a combination of organic growth and suitable acquisitions in line with strategy.

 

For the purposes of Rule 2.8 of the City Code, Costain reserves the right to announce an offer or possible offer or make or participate in an offer or possible offer for Mouchel (and/or take any other action which would otherwise be restricted under Rule 2.8 of the City Code) within the next six months following the date of this announcement:

 

(i) with the agreement or recommendation of the Board of Mouchel;

 

(ii) following the announcement by or on behalf of a third party of a firm intention to make an offer for Mouchel or following the announcement of a possible offer for Mouchel;

 

(iii) following the announcement by Mouchel of a "whitewash" proposal or a reverse takeover; or

 

(iv) if there is a material change of circumstances.

 

Enquiries:

 

Costain Group PLC

Tel: +44 1628 842 444

Andrew Wyllie, Chief Executive

Tony Bickerstaff, Finance Director

Graham Read, Communications Director

Investec Investment Banking (Financial adviser & broker to Costain)

Tel: +44 20 7597 5970

David Currie

Charles Batten

James Rudd

College Hill (PR adviser to Costain)

Tel: +44 20 7457 2020

Mark Garraway

Mike Davies

 

A copy of this announcement will shortly be available, free of charge, on the Group's website at www.costain.com

 

Investec (which is authorised and regulated in the United Kingdom by the Financial Services Authority) is acting exclusively for Costain and for no one else in connection with the possible offer and will not be responsible to anyone other than Costain for providing the protections afforded to Investec clients nor for providing advice in relation to the possible offer or any other matters referred to in this announcement.

 

This announcement does not constitute an offer to purchase any securities, or an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any offer to purchase or sell securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. No offering of securities may be made in the United States except pursuant to registration under the US Securities Act of 1933 or an exemption from registration.

 

The release, distribution or publication of this announcement in jurisdictions other than the UK may be restricted by law and therefore any persons who are subject to the laws of any jurisdiction other than the UK should inform themselves about and observe any applicable requirements. If you are resident outside the UK, you are responsible for first satisfying yourself as to the full observance of the laws and regulatory requirements of your jurisdiction.

 

Unless otherwise determined by Costain, this announcement and any proposed offer will not be made, directly or indirectly, in or into any jurisdiction where to do so would violate the laws of that jurisdiction (a "Restricted Jurisdiction") or the United States, or by the use of any means or instrumentally (including, without limitation, telex, facsimile transmission, telephone, internet or other forms of electronic communication) of interstate or foreign commerce, or of any facility of a national securities exchange of any Restricted Jurisdiction or the United States. Unless so determined by Costain, the proposed offer will not be capable of acceptance by any such use, means or instrumentally or facility of any Restricted Jurisdiction or the United States.

 

Copies of this announcement and documents relating to any offer will not be, and must not be, directly or indirectly, mailed or otherwise forwarded (including, without limitation, by telex, facsimile transmission, telephone, internet or other forms of electronic communication), distributed or sent in, into or from any Restricted Jurisdiction or the United States.

 

Forward looking statements

 

This announcement contains statements about Costain that are or may be forward looking statements. All statements other than statements of historical facts included in this announcement may be forward looking statements. Without limitation, any statements preceded or followed by or that include the words "targets", "plans" "believes", "expects", "aims", "intends", "will", "may", "anticipates", "estimates", "projects" or words or terms of similar substance or the negative thereof, are forward looking statements.

 

Such forward looking statements involve risks and uncertainties that could significantly affect expected results and are based on certain key assumptions. Many factors could cause actual results to differ materially from those projected or implied in any forward looking statements. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward looking statements, which speak only as of the date hereof. Costain disclaims any obligation to update any forward looking or other statements contained herein, except as required by applicable law.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OFDLLFLSSTISIIL
Date   Source Headline
4th Jun 20242:41 pmRNSCostain Secures New AMP8 Framework Agreement
3rd Jun 202410:39 amRNSTotal Voting Rights
23rd May 20243:16 pmRNSAdditional Listing
16th May 20244:10 pmRNSOrdinary Share Nominal Value Reduction
16th May 20244:09 pmRNSResult of AGM
16th May 20247:00 amRNSAGM Statement
1st May 202410:41 amRNSTotal Voting Rights
25th Apr 202411:41 amRNSScrip Dividend Reference Price
9th Apr 20244:16 pmRNSDirector/PDMR Shareholding
9th Apr 20241:32 pmRNSDirector/PDMR Shareholding
9th Apr 20249:33 amRNSAnnual Report and Accounts and Notice of 2024 AGM
4th Apr 20249:55 amRNSAdditional Listing
15th Mar 20248:30 amRNSKey Partner for Landmark Carbon Capture Project
12th Mar 20247:01 amRNSDirectorate Change
12th Mar 20247:00 amRNS2023 Full Year Results
27th Feb 202412:06 pmRNSInvestor Presentation via Investor Meet Company
10th Jan 20247:00 amRNSAMP8 Water Framework Win with NWG & Trading Update
2nd Jan 202412:56 pmRNSBlock listing Interim Review
1st Nov 202312:15 pmRNSTotal Voting Rights
27th Oct 20231:00 pmRNSDirector/PDMR Shareholding
25th Oct 20231:00 pmRNSAdditional Listing
19th Oct 20231:00 pmRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSDirectorate Change
28th Sep 202312:00 pmRNSScrip Dividend Reference Price
25th Sep 20237:00 amRNSCostain and Ofwat Water Seminar
8th Sep 20232:26 pmRNSBlock listing Interim Review
5th Sep 20237:00 amRNSDividend Declaration
23rd Aug 20237:00 amRNSResults for the six months ended 30 June 2023
16th Aug 202310:00 amRNSInterim Results Investor Q&A
26th Jul 20237:00 amRNSCostain Refinancing of Bank and Bonding Facilities
17th Jul 20237:00 amRNSCostain Announces Key Contract Extension
30th Jun 20237:00 amRNSNew Payment Plan with Pension Scheme Trustee
22nd Jun 202310:38 amRNSCostain Appointed Magnox Decommissioning Framework
8th Jun 20234:17 pmRNSUpdate Regarding A66 Project
11th May 20234:49 pmRNSResult of AGM
11th May 20237:00 amRNSAGM Statement
20th Apr 20239:40 amRNSExternal Appointment
6th Apr 20232:29 pmRNSGrant of Share Plan Awards
6th Apr 202311:51 amRNSHolding(s) in Company
4th Apr 202310:33 amRNSNotice of AGM and Annual Report and Accounts
30th Mar 202312:58 pmRNSLong Term Incentive Plan - Listing Application
14th Mar 20237:00 amRNSResults For The Year Ended 31 December 2022
30th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20231:09 pmRNSBlock Listing Six Monthly Return
21st Dec 202212:47 pmRNSDirector/PDMR Shareholding
29th Nov 20227:00 amRNSCostain Partners with Heathrow Airport
21st Nov 20227:00 amRNSExtension of Bank Debt and Bonding Facilities
1st Nov 20224:42 pmRNSDirector/PDMR Shareholding
30th Sep 20222:32 pmRNSA303 Delivery Assurance Partnership
27th Sep 20227:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.